Biochemical characterization of plasma in amyotrophic lateral sclerosis: Amino acid and protein composition

被引:7
作者
Palma, A
De Carvalho, M
Barata, N
Evangelista, T
Chicau, P
Regalla, M
Costa, J
机构
[1] Inst Tecnol Quim & Biol, Lab Glycobiol, P-2781901 Oeiras, Portugal
[2] Hosp Santa Maria, Dept Neurol, Lisbon, Portugal
[3] FML, IMM, EMG Lab, Lisbon, Portugal
[4] Inst Biol Expt & Tecnol, Oeiras, Portugal
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2005年 / 6卷 / 02期
关键词
plasma; amino acid; alpha; 2-macroglobulin; haptoglobin;
D O I
10.1080/14660820410021320a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this work, we have studied the amino acid and protein composition of the plasma from a group of 32 ALS patients. As controls, groups of 10 healthy subjects (HC) and 32 patients with other neuromuscular disorders have been analysed. When the HC group was compared with the ALS group there were significant decreases of His ( 39 +/- 18 to 24 +/- 9 mu M, p<0.01) and Ala ( 313 +/- 62 to 237 +/- 66 mM, p<0.05), and a significant increase of Asn ( 89 +/- 41 to 118 +/- 24 mu M, p<0.05), for the ALS group. When the three groups were compared, we observed significant decreased concentrations of Ser, His, Thr, Ala, Arg, Tyr, Met, Cys, Ile, and significant increases of Asn, Phe and Lys. An increase of proteolytic products of alpha 2-macroglobulin (alpha 2-M), an acute-phase serum glycoprotein that functions as a protease inhibitor, has been observed for a subgroup of ALS patients by Western blot. Furthermore, the detection of alpha 2-M during disease progression has shown increases of the intact subunit and of a proteolytic product for two of the four patients analysed. Another acute-phase glycoprotein, haptoglobin, which regulates haemoglobin degradation, was not increased for the same group of patients. The results obtained suggested that diet supplementation with His and Ala and modulation of alpha 2-M might have some beneficial effects on the course of ALS.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 29 条
[1]   STUDIES OF PROTEASE INHIBITORS IN THE SERA OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS [J].
ADACHI, N ;
SHOJI, S .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 89 (2-3) :165-168
[2]   Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients [J].
Almer, G ;
Teismann, P ;
Stevic, Z ;
Halaschek-Wiener, J ;
Deecke, L ;
Kostic, V ;
Przedborski, S .
NEUROLOGY, 2002, 58 (08) :1277-1279
[3]   Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis [J].
Beuche, W ;
Yushchenko, M ;
Mäder, M ;
Maliszewska, M ;
Felgenhauer, K ;
Weber, F .
NEUROREPORT, 2000, 11 (16) :3419-3422
[4]   AMINO-ACID SEQUENCE OF ALPHA CHAINS OF HUMAN HAPTOGLOBINS [J].
BLACK, JA ;
DIXON, GH .
NATURE, 1968, 218 (5143) :736-+
[5]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[6]   Unraveling the mechanisms involved in motor neuron degeneration in ALS [J].
Bruijn, LI ;
Miller, TM ;
Cleveland, DW .
ANNUAL REVIEW OF NEUROSCIENCE, 2004, 27 :723-749
[7]  
CAMU W, 1993, ACTA NEUROL SCAND, V88, P51
[8]   Blood-brain barrier damage induces release of α2-macroglobulin [J].
Cucullo, L ;
Marchi, N ;
Marroni, M ;
Fazio, V ;
Namura, S ;
Janigro, D .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (04) :234-241
[9]  
ENGHILD JJ, 1989, J BIOL CHEM, V264, P8779
[10]   OCCURRENCE OF REDUCED ALPHA-2-MACROGLOBULIN AND LOWERED PROTEASE INHIBITING CAPACITY IN PLASMA OF AMYOTROPHIC LATERAL SCLEROSIS PATIENTS [J].
FESTOFF, BW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 421 (DEC) :369-376